During the time of the novel coronavirus disease 2019 (COVID-19) pandemic, it has been
crucial to search for novel antiviral drugs from plants and well as other natural sources as …

Background Cannabidiol (CBD) is one of the main phytocannabinoids found in Cannabis
sativa. In contrast to Δ9-tetrahydrocannabinol, it has a low affinity for cannabinoid receptors …

Importance: Owing to its anti-inflammatory properties and antiviral “in vitro” effect against
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), cannabidiol (CBD) has …

Antimicrobial resistance has emerged as a global health crisis and, therefore, new drug
discovery is a paramount need. Cannabis sativa contains hundreds of chemical constituents …

Cannabidiol (CBD) is the main non-psychotropic cannabinoid derived from cannabis
(Cannabis sativa L., fam. Cannabaceae). CBD has received approval by the Food and Drug …

These are uncertain times as we attempt to manage our lives during the Coronavirus Covid-
19 pandemic. It is not surprising, as possible treatments for Covid-19 are discussed, that …

In the present study, the antiviral activity of cannabinoids isolated from Cannabis sativa L.
was assessed in vitro against a panel of SARS-CoV-2 variants, indicating cannabidiolic acid …

The replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
mediated by its main protease (Mpro), which is a plausible therapeutic target for coronavirus …

Cannabidiol (CBD) can prevent the inflammatory response of SARS-CoV-2 spike protein in
Caco-2-cells. This action is coupled with the inhibition of IL-1beta, IL-6, IL-18, and TNF …

Background: One of the main public health strategies adopted at the beginning of the COVID-
19 pandemic consisted of implementing strict lockdowns to stop the transmission of the …